rs397514716
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 16P and 4B. PVS1PP5_Very_StrongBS2
The NM_001127217.3(SMAD9):c.880C>T(p.Arg294*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,613,936 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001127217.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- pulmonary arterial hypertensionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pulmonary hypertension, primary, 2Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMAD9 | NM_001127217.3 | c.880C>T | p.Arg294* | stop_gained | Exon 5 of 7 | ENST00000379826.5 | NP_001120689.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMAD9 | ENST00000379826.5 | c.880C>T | p.Arg294* | stop_gained | Exon 5 of 7 | 5 | NM_001127217.3 | ENSP00000369154.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152110Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251470 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461826Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727228 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152110Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74316 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Pulmonary hypertension, primary, 2 Pathogenic:4
This sequence change creates a premature translational stop signal (p.Arg294*) in the SMAD9 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMAD9 are known to be pathogenic (PMID: 19419974, 31727138). This variant is present in population databases (rs397514716, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with clinical features of SMAD9-related conditions (PMID: 21920918, 29631995, 29650961). ClinVar contains an entry for this variant (Variation ID: 56970). For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
Published functional studies demonstrate a primary defect in non-canonical SMAD-mediated microRNA processing, consistent with a loss-of-function effect on the protein (PMID: 21920918); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25830521, 29650961, 29631995, 31727138, 35130036, 23590310, 21920918)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at